A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Alcon Research109 enrolled

Overview

The purpose of the study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

109

Conditions

Open-angle Glaucoma Ocular Hypertension

Interventions

Travoprost, InvestigationalDRUG

One drop in study eye once daily for 13 days

Travoprost (TRAVATAN)DRUG

One drop in study eye once daily for 13 days

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adult patients of either sex of any race diagnosed with open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component) or ocular hypertension. * Other protocol-defined inclusion criteria may apply. Exclusion Criteria: * Under age 18. * Other protocol-defined exclusion criteria may apply.

Outcomes

Primary Outcomes

Mean IOP

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.